Aliada Therapeutics

Boston, United States

Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases.

$32.0M raised

Dec 2022

Venture - Series Unknown

Biotechnology Health Care Life Science Medical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Aliada Therapeutics

How much funding has Aliada Therapeutics raised?

Aliada Therapeutics has raised $32.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in December 2022.

Where is Aliada Therapeutics headquartered?

Aliada Therapeutics is headquartered in Boston, United States.

What does Aliada Therapeutics do?

Aliada Therapeutics is a biotechnology company developing novel therapies to treat central nervous system diseases.

What stage is Aliada Therapeutics at?

Aliada Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 30, 2022.

MLA

"Aliada Therapeutics — Funding & Investors." VCBacked, December 30, 2022, https://www.vcbacked.co/company/aliada-therapeutics. Accessed July 4, 2026.

APA

VCBacked. (2022). Aliada Therapeutics — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/aliada-therapeutics

Wikipedia (cite web)

{{cite web |title=Aliada Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aliada-therapeutics |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 30, 2022.